As of January 22, 2025, Annovis Bio (ANVS) has a market cap of $73.263 million USD. According to our data, Annovis Bio is ranked No.7924 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $73.26 M |
5.57%
|
Dec 31, 2024 | $69.40 M |
-73.10%
|
Dec 29, 2023 | $0.26 B |
39.24%
|
Dec 30, 2022 | $0.19 B |
-23.61%
|
Dec 31, 2021 | $0.24 B |
133.16%
|
Dec 31, 2020 | $0.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Market Cap | = | ANVS Stock Price | * | ANVS Shares Outstanding |
= | $5.31 | * | 13.80 M | |
= | $73.26 M |